View the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 25.
https://www.oncotarget.com/archive/v12/i25/
Research Paper (Cover) - “Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas”
https://doi.org/10.18632/oncotarget.28132
Research Paper - “Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasound”
https://doi.org/10.18632/oncotarget.28139
Research Paper - “Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma”
https://doi.org/10.18632/oncotarget.28147
Editorial - “Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas”
https://doi.org/10.18632/oncotarget.28018 (PDF Download)
Research Perspective - “Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects”
https://doi.org/10.18632/oncotarget.28088
Keywords - lung cancer, tumor microenvironment, radiomics, breast cancer, oral squamous cell carcinoma (OSCC), glioblastoma, cell fusion, cancer, science, research, oncology
About Oncotarget
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com/ or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/oncotargetyoutube
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget
Oncotarget is published by Impact Journals, LLC. Please visit https://www.impactjournals.com/ or connect with @ImpactJrnls
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.